NFKB1 and COVID-19: However, this particular research [32] confirmed that TNF-α/NF-κβ/renalase axis exhibits favorable outcomes, summarized as reduced cell cytotoxicity (validated as reduced LDH levels), and apoptosis (measured as decreased caspase-3 activity), a phenomenon that may be of a great advantage in COVID-19.